The Department of Health and Human Services awarded $101 million, mostly to rural communities, to fight the opioid epidemic.

Top news of the week from Pharmacy Times®.
 

Belantamab mafodotin-blmf is the first anti-BCMA therapy approved by the FDA for the treatment of patients with relapsed or refractory multiple myeloma who received at least 4 prior therapies.

New testing method may improve the speed, handling time, and cost of laboratory tests for coronavirus disease 2019.

In a world increasingly influenced by technology, there is ample opportunity to leverage automation within pharmacies that can not only improve operations, but support patient wellness.

Study suggests the ability of younger children to transmit COVID-19 may have been under-recognized because of the rapid, long-term closure of schools and daycares during the pandemic.

Introducing an online PharmD program presents a unique set of challenges for educators.

JD Power 2020 US Pharmacy Study ranks Good Neighbor Pharmacy highest among brick-and-mortar chain drug store pharmacies in customer satisfaction.

Researchers find a link between bacterial infections and the development of late diabetic complications and coronary heart disease.

A new study found that Medicare Part D prescription drug insurance plans largely favor generic drugs over brand-name counterparts, despite previous reports to the contrary.

Study finds that health care systems need to develop additional strategies to protect workers from COVID-19.
 

A review of the potential agents or regimens that Allison Butts, PharmD, BCOP, is looking forward to seeing transition from metastatic management to the early stage setting.